Showing results (1231-1240 of 1,242) with videos related to

Sort By:
Pageof 125
Cancer Cell International|September 19, 2022
Intratumoral delivery of TransCon™ TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine inductionLuis Alejandro Zúñiga, Torben Leßmann, Karan Uppal, et al.
Plos One|September 15, 2018
A case-control study of breast cancer risk factors in 7,663 women in MalaysiaMin-Min Tan, Weang-Kee Ho, Sook-Yee Yoon, et al.
Journal of Medical Genetics|October 11, 2017
Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from MalaysiaWei Xiong Wen, Jamie Allen, Kah Nyin Lai, et al.
IEEE Transactions on Bio-Medical Engineering|February 26, 2019
Design and In Vivo Verification of a CMOS Bone-Guided Cochlear Implant MicrosystemXin-Hong Qian, Yi-Chung Wu, Tzu-Yi Yang, et al.
Scientific Data|June 13, 2025
Spatial occurrence records and distributions of tropical Asian butterfliesEugene Yu Hin Yau, Emily E Jones, Toby Pak Nok Tsang, et al.
Cellular & Molecular Immunology|May 17, 2022
Retinoic acid signaling acts as a rheostat to balance Treg functionGovindarajan Thangavelu, Gabriela Andrejeva, Sara Bolivar-Wagers, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 15, 2024
Neurological manifestations of SARS-CoV-2 infection in children in Taiwan: A cross-section, multicenter studyYen-Ju Chu, Lee-Chin Wong, Che-Sheng Ho, et al.
ACS Infectious Diseases|July 5, 2021
In Vivo Activity of Repurposed Amodiaquine as a Host-Targeting Therapy for the Treatment of AnthraxMikhail Martchenko Shilman, Gloria Bartolo, Saleem Alameh, et al.
Environment International|July 9, 2013
Perfluoroalkyl acids in the Canadian environment: multi-media assessment of current status and trendsSarah B Gewurtz, Sean M Backus, Amila O De Silva, et al.
Journal for Immunotherapy of Cancer|July 11, 2022
TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancerDavid B Rosen, Anne Månsson Kvarnhammar, Burkhardt Laufer, et al.
Pageof 125